Evidence map›Paper›PMID 32799658›Full record

ArticleAmerican journal of physiology. Endocrinology and metabolism2020

Pradip K Saha, Mark P Hamilton, Kimal Rajapakshe, Vasanta Putluri, Jessica B Felix, Peter Masschelin, Aaron R Cox, Mandeep Bajaj, Nagireddy Putluri, Cristian Coarfa and 1 more

Open access · greenAbstract read
In one paragraph

Article in American journal of physiology. Endocrinology and metabolism, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it, 24 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Review
  17. Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Pradip K SahaDivision of Diabetes, Endocrinology, and Metabolism, Department of Medicine, Baylor College of Medicine, Houston, Texas.
Mark P HamiltonDepartment of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas.
Kimal RajapaksheDepartment of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas.
Vasanta PutluriDepartment of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas.
Jessica B FelixDepartment of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas.
Peter MasschelinDepartment of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas.
Aaron R CoxDivision of Diabetes, Endocrinology, and Metabolism, Department of Medicine, Baylor College of Medicine, Houston, Texas.
Mandeep BajajDivision of Diabetes, Endocrinology, and Metabolism, Department of Medicine, Baylor College of Medicine, Houston, Texas.
Nagireddy PutluriDepartment of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas.
Cristian CoarfaDepartment of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas.
Sean M HartigDivision of Diabetes, Endocrinology, and Metabolism, Department of Medicine, Baylor College of Medicine, Houston, Texas.ORCID 0000-0002-2695-2072
Baylor College of Medicine · US

Funding

Hematology Training ProgramT32DK060445 · NIDDK · BAYLOR COLLEGE OF MEDICINE · PI GOODELL, MARGARET A. · 2002 to 2023
$8.3M
METABOLIC IMPACTS OF TYPE II INTERFERON SIGNALS IN OBESITYR01DK114356 · NIDDK · BAYLOR COLLEGE OF MEDICINE · PI HARTIG, SEAN · 2017 to 2025
$4.6M
A novel axis regulates adipocyte plasticityK01DK096093 · NIDDK · BAYLOR COLLEGE OF MEDICINE · PI HARTIG, SEAN · 2013 to 2015
$444k
Regulation of SYSTEMIC INSULIN SENSITIVITY by miRNA-30aR03DK105006 · NIDDK · BAYLOR COLLEGE OF MEDICINE · PI HARTIG, SEAN · 2016 to 2017
$159k
HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) R01114356NIDDK NIH HHS K01 DK096093NIDDK NIH HHS R01 DK114356NIDDK NIH HHS R03 DK105006NIDDK NIH HHS T32 DK060445
6 · The paper itself

Abstract

MicroRNA-30a (miR-30a) impacts adipocyte function, and its expression in white adipose tissue (WAT) correlates with insulin sensitivity in obesity. Bioinformatic analysis demonstrates that

Indexed as

Adipocytes, BrownAdipocytes, WhiteAnimalsBlood GlucoseCells, CulturedFatty Acid-Binding ProteinsGene Regulatory NetworksHumansHypoglycemic AgentsInsulin ResistanceMetabolomicsMiceMicroRNAsOligopeptidesOrganelle BiogenesisPPAR gammaADAM15 protein (286-297)Blood GlucoseFABP4 protein, humanFatty Acid-Binding ProteinsHypoglycemic AgentsMicroRNAsMIRN30a microRNA, mouseMIRN30b microRNA, humanOligopeptidesPPAR gammaRosiglitazonemetabolismmicroRNAmitochondriaPPARγsubcutaneous adipocytes

Identifiers

PMID32799658
PMCPMC7864240
OpenAlexW3059242612

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.